Outcomes With Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Intervention
JACC: Cardiovascular Interventions(2009)
Abstract
Conclusions Treatment of SVG lesions with DES vs. BMS is effective in reducing TVR at 9 months, although most of this advantage is lost at 2 years. The DES seem safe with less death or myocardial infarction, although selection bias might have affected these results. Our data suggest that DES might have short-term advantages over BMS in SVG lesions with diameter <3.5 mm.
MoreTranslated text
Key words
drug-eluting stents,saphenous vein grafts
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined